Search Results - "Oterino Moreira, I"

5PSQ-141 Falls in elderly patients and chronic consumption of anxiolytic benzodiazepines by Morona Minguez, I, Meseguer Barros, CM, Oterino Moreira, I, Jamart Sanchez, L, Sollano-Sancho, I, Moriel Sanchez, C

“…Background and ImportanceFalls in the elderly have a multifactorial component, among these factors, one of the main causes is chronic consumption of…”
Get full text

5PSQ-120 Impact of the COVID-19 pandemic on the use of antimicrobials in primary and hospital care by Oterino Moreira, I, Escudero Vilaplana, BM, Silva Riádigos, GM, Meseguer Barros, CM, Picazo Sanchiz, G, Jamart Sanchez, L, Sanz Márquez, S, Perez Encinas, M

“…Background and importanceThe characteristics of the patient who requires health care are different between primary care (PC) and hospital care (HC). The…”
Get full text

5PSQ-154 Impact of the COVID-19 pandemic on antimicrobial consumption and antimicrobial resistance by Oterino Moreira, I, De La Casa Domingo, L, Valverde Canovas, JF, Sanz Marquez, S, Zamorano Mendez, P, Herrera Carranza, S, Moreno Nuñez, L, Goyanes Galan, MJ, Perez Encinas, M

“…Background and importanceRecent studies have reported an increase of antimicrobial use during the COVID-19 pandemic. The impact of overuse on the propagation…”
Get full text

5PSQ-221 Safety profile of experimental therapies used in the COVID-19 pandemic based on data from the National Minimum Data Set by Oterino Moreira, I, Sanz Marquez, S, Carrasco Piernavieja, L, Zhan Zhou, E, Martinez Simón, JJ, Salvador Llana, I, Lorenzo Martínez, S, Morales Catalan, MDC, Plo Seco, I, Roldan Navarro, P, Pérez Encinas, M

“…Background and importanceIn response to the COVID-19 pandemic, scientific societies and regulatory agencies quickly reviewed any available evidence to fill the…”
Get full text

4CPS-126 Effectiveness and safety of nab-paclitaxel in patients with metastatic adenocarcinoma of the pancreas in a real-world setting by Plo Seco, I, Sanmartin Fenollera, P, Roldan Navarro, P, Martinez Simon, JJ, Oterino Moreira, I, Toro Chico, P, Perez Encinas, M

“…BackgroundNab-paclitaxel was approved for the treatment of metastatic adenocarcinoma of pancreas (mPAC), as a first treatment in combination with…”
Get full text